"Xeloda" (capecitabine): nga ritenga utu. Hea ki te hoko Xeloda iti?

Te faaineineraa "Xeloda" (capecitabine) no ki te kāwai o cytostatic. Ko tōna whakauru matua kaha faanane te tupu me te tini o tere wehewehe pūtau i roto i te tinana, e ngā mārere, reira whakapataritari ratou apoptosis (mate programmed).

Kei hea te tarukino ko "Xeloda" hoko iti

A, no te hoko taero anticancer, e maha fehangahangai tūroro ki te raruraru o te utu tiketike o te moni whakaritea. A ka whakaaro koutou i te meka e hiahia ratou te manawanui i roto i ngā tau nui, kia mea nui atu te pouri o te āhuatanga. He aha ki te mahi?

I roto i ngā take pērā, ka taea e koe te whakamahi i te kano - tikanga he i te taua hanganga me te tōtika taua rite te waitohu-ingoa tarukino. Ko reira utu reira i roto i tenei take, ko te nui ngawari te, mai kua riro te u te raihana e pā ana ki te hamaniraa, e kore e whakapau pūtea mō te whanaketanga me te whakamātautau. Hokona te raau taero whānui e pā ana i te utu i te utu taea i runga i te pae WWW.ONKO24.COM.

Whakatauritea, i roto i Russia i te tarukino "Xeloda" utu he 16 000 moni., A i roto i te rauemi tohua ona kano Capegard-500, whakaputaina e te maro Indian Cipla Ltd., utu e pā ana ki 10 mano moni. I roto i tenei take, ka taea e te manawanui e tino e hokona ia te tikanga e kore e conceding tetahi ki te tarukino taketake.

iteraa papû

Drug "Xeloda" tohutohu mō te whakamahi i homai nei ki tou whakarongo, he ngohengohe ki te absorption tere, whakahohe i roto i te puku, me te kore i roto i te kopa e karapoti ana. Nā ki tenei i reira ko te roa o ngā pūtau kino, me te aukati i te tupu o te whanaketanga puku.

"Xeloda" whakaritea e te mātanga. Mahi i te reira i roto i te mau huru e whai ake nei:

• i roto i te huinga ki te faaineineraa o "Docetaxel" i roto i te maimoatanga o te mate pukupuku uma (metastatic ranei rohe meangia), i roto i te take o te kore o te tono o te maha o taero anthracycline;
• i roto i te take o te Tātarihia te mate pukupuku metastatic colorectal;
• ki te mate pukupuku pekitīlia matatau;
• mate pukupuku o te kopirua.

inenga

I roto i te arumoni wātea papa "Xeloda" 500mg (120 RW. I roto i te tākai) me 150 mg (60 RW.). Me ratou ki te tango i te hawhe haora i muri i ngā kai ki te wai. Ko te inenga rā ko te 1250 mg ia m² o mata tinana.

Inu i te rongoā rua he ra - te ata me te ahiahi - mō te 3 wiki aru e te wiki riro te manawanui e ki te tango i te mea kiano i matao.

I roto i ngā therapy taumahi "Xeloda" titau tarukino pipiki tino ki tona hototahi ki ētahi atu taero, whakaaro nga peculiarities o te mate me te huru o te manawanui.

contraindications

I roto i ētahi wā, "Xeloda" Kei te kore tautapatia:

1. A, no te hypersensitive ki ona wāhanga.
2. A, no te whakahaere tukutahi o te tarukino "Sorivudin" ranei analogues ona;
3. A, no te Tātarihia te nui iti hoki tākihi;
4. Women i roto i te hapū, me te hohipera;
5. Tamariki ki runga ki te 18 tau.

hiahiatia tūpato te i roto i te tūroro ki te tūroro mate ngakau coronary i 60 tau o te tau pakeke ranei me i roto i te maimoatanga tukutahi ki anticoagulants-waha.

pānga taha

I roto i te rongoā tarukino "Xeloda" (500 150 ranei mg) kia whakawhanake ngā pānga taha e whai ake nei:

• korere;
• stomatitis;
• ngoikore, rohirohi nui;
• whakapairuaki, retching;
• nui haere sleepiness me te lethargy;
• syndrome ringa-waewae.

I tua atu, kitea etahi tūroro i kōtītiti i roto i te mahi kūnatu i roto i te huru kiri me te i roto i te mahi o nga whekau Cardiovascular, pūnaha romahā, me ētahi atu.